Nosopharm

📍 Lyon, France🗓 Founded 2009👥 7 employees💰 Last funded Mar 2017
Biotechnology🌐 nosopharm.com
Website LinkedIn
Nosopharm is an innovative biotechnology company headquartered in Lyon (France) and specialized in the research and development of new molecules to combat antimicrobial resistance (AMR). The mission of Nosopharm is to discover and develop novel first-in-class anti-infectives addressing unmet medical needs. The innovative anti-infective drug discovery platform developed by Nosopharm is based on the therapeutic exploitation of a very original bioresource: the bacterial genera Xenorhabdus and Photorhabdus.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2009
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in Nosopharm?
Nosopharm has 1 investors on record on gritt.io and 1 late-stage investors.
When did Nosopharm last raise funding?
The most recent investment in Nosopharm recorded on gritt.io was in March 2017.
When was Nosopharm founded?
Nosopharm was founded in 2009.
What industry is Nosopharm in?
Nosopharm operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Nosopharm based?
Nosopharm is headquartered in Lyon, France.